SUpport From PEeRs to Expand Access Study - Community
ConditionDepression, Anxiety
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-100
SponsorUniversity of California, Berkeley
About this trial
Investigators will evaluate the implementation of an evidence-based, Spanish-language, digital, cognitive-behavioral therapy (dCBT) intervention (SilverCloud) in the Mission community for Latino patients with depression and/or anxiety. 213 participants will be enrolled in a one-armed trial comparing self-guided vs. supported dCBT (SilverCloud).
Eligibility criteria
Qualifiers
PHQ-9 ≥ 10 or GAD-7 ≥ 8
Has access to the Internet via smartphone and/or broadband at home, and basic level of technological literacy or willingness to undergo a brief technology use training
≥18 years of age
Preference for receiving medical care in Spanish
Disqualifiers
Currently receiving psychotherapy, as this treatment will be offered as a frontline treatment for depression and anxiety, however, patients are allowed to be referred to treatment while participating in this study and initiation of treatment will be monitored and considered in analyses
Visual, hearing, voice, or motor impairment or illiteracy that would prevent completion of study procedures
Diagnosis of a psychotic disorder, bipolar disorder, dissociative disorder, or substance use disorder
Severe suicidality (as assessed by expressing suicidal ideation, plan, and intent). Although procedures with back-up plans are in place for patients who develop suicidality (see Human Subjects Section), patients assessed with severe suicidality will be referred to more-intensive treatment resources.
Trial design
Treatments tested in this trial
- Behavioral: Supported dCBT
- Behavioral: Unsupported dCBT
Treatment groups
213 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of California, Berkeley
Lead sponsor
University of California, Irvine
Collaborator
University of California, San Francisco
Collaborator
Source ClinicalTrials.gov